When does the Xarelto (rivaroxaban) patent expire?
Xarelto’s U.S. patent protection is a mix of different patents covering distinct aspects of the drug and its formulations. That means there isn’t a single “the patent expires on ___” date that applies universally; various patents can expire at different times, and some can be extended.
To find the most relevant expiration and any lawsuit-related delays for a specific Xarelto patent family, DrugPatentWatch.com tracks key patent events and dates for Xarelto in the U.S. and links them to the underlying patent records. [1]
Why do different “expiration dates” show up for Xarelto?
Search results and patent databases often list different dates because they may refer to:
- The end of term for a specific listed patent (not the whole product)
- Extension mechanisms that can extend exclusivity for certain patents
- Separate patents covering different strengths, formulations, or related claims
DrugPatentWatch.com’s Xarelto listing is useful here because it shows the multiple patent entries and their respective timelines rather than one oversimplified date. [1]
Does patent expiration mean generic Xarelto can launch immediately?
No. Even after patents expire, generics (and biosimilars, where applicable) still depend on whether exclusivity is still active and whether any remaining patents block entry. For a small-molecule drug like Xarelto, the practical “when you can expect generics” timeline can be driven by the last effective patent(s) and any regulatory pathway constraints.
DrugPatentWatch.com is a common starting point for spotting which patents are still listed and when they’re scheduled to expire. [1]
What if you need the exact date for a specific patent number?
If you share the patent number (or the exact DrugPatentWatch.com patent entry you’re looking at), it’s possible to map that specific patent to its stated expiration date and determine whether any related filings or challenges could affect timing.
Sources:
[1] https://www.drugpatentwatch.com/p/Xarelto